Drugs / Umbilical Cord Blood (UCB)
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT01451502 | Oct 2011 → Sep 2026 overdue | hematopoietic and lymphoid system neoplasm, lymphatic system disorder | Masonic Cancer Center, University of Minnesota | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Umbilical Cord Blood (UCB) | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01451502 ↗ |
| Route | Intravenous | “the UCB unit will be infused through a central line according to institutional guidelines.” NCT01451502 ↗ |